1. Home
  2. CHD vs RPRX Comparison

CHD vs RPRX Comparison

Compare CHD & RPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Church & Dwight Company Inc.

CHD

Church & Dwight Company Inc.

HOLD

Current Price

$96.19

Market Cap

22.4B

ML Signal

HOLD

Logo Royalty Pharma plc

RPRX

Royalty Pharma plc

HOLD

Current Price

$49.55

Market Cap

19.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHD
RPRX
Founded
1846
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.4B
19.5B
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
CHD
RPRX
Price
$96.19
$49.55
Analyst Decision
Buy
Strong Buy
Analyst Count
17
5
Target Price
$102.18
$51.40
AVG Volume (30 Days)
1.6M
2.5M
Earning Date
05-01-2026
05-06-2026
Dividend Yield
1.28%
1.90%
EPS Growth
27.43
N/A
EPS
3.02
1.78
Revenue
$6,203,200,000.00
$2,378,193,000.00
Revenue This Year
$0.25
$38.63
Revenue Next Year
$3.65
$4.73
P/E Ratio
$32.10
$28.12
Revenue Growth
1.57
5.06
52 Week Low
$81.33
$31.97
52 Week High
$106.04
$50.47

Technical Indicators

Market Signals
Indicator
CHD
RPRX
Relative Strength Index (RSI) 52.36 59.14
Support Level $91.34 $35.34
Resistance Level $96.62 $50.08
Average True Range (ATR) 2.12 0.87
MACD 0.35 -0.06
Stochastic Oscillator 49.83 61.59

Price Performance

Historical Comparison
CHD
RPRX

About CHD Church & Dwight Company Inc.

Church & Dwight is the leading global producer of baking soda. Its portfolio extends beyond its legacy category to include laundry products, cat litter, oral care, deodorant, and nasal care, all sold under the Arm & Hammer brand. Its brands also include Batiste, OxiClean, Vitafusion, Hero, and TheraBreath, which, together with Arm & Hammer, account for around 70% of its annual sales and profits. Most recently, the firm added Touchland and its hand sanitizer business to its fold. Even as it works to expand its product reach, Church & Dwight still derives around 80% of its sales from its home market in the US.

About RPRX Royalty Pharma plc

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.

Share on Social Networks: